✦ LIBER ✦

Chemotherapy related fatal neurotoxicity during induction in acute lymphoblastic leukemia

✍ Scribed by Munni Ray; R K Marwaha; Amita Trehan

Publisher: Springer-Verlag
Year: 2002
Tongue: English
Weight: 288 KB
Volume: 69
Category: Article
ISSN: 0019-5456
DOI: 10.1007/bf02859383

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nephrotic syndrome developing during ind

Nephrotic syndrome developing during induction chemotherapy for childhood acute lymphoblastic leukemia

✍ Chanel Prestidge; Shahrad Rod Rassekh; Douglas G. Matsell 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 265 KB

Stenotrophomonas maltophilia infection r

Stenotrophomonas maltophilia infection related mortality during induction in childhood acute lymphoblastic leukemia

✍ Abbas, Adil A.H. ;Fryer, Christopher J.H. ;Felimban, Sami K. ;Yousef, Abdulmotta 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

The diagnosis of NBL was based on histopathologic findings and biochemical markers, but the diagnosis of histiocytosis (LCH) was not definite, because it was based on conventional morphology alone. The unfavorable NBL factors required aggressive treatment with drugs that are active in LCH treatment

Acute parotitis during induction therapy

Acute parotitis during induction therapy includingl-asparaginase in acute lymphoblastic leukemia

✍ S. Sica; L. Pagano; P. Salutari; A. Di Mario; S. Rutella; G. Leone 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 230 KB

Acute fatal myeloencephalopathy after co

Acute fatal myeloencephalopathy after combined intrathecal chemotherapy in a child with acute lymphoblastic leukemia

✍ von der Weid, Nicholas X. ;de Crousaz, Henriette ;Beck, Daniel ;Deonna, Thierry 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 806 KB

We report a case of a fatal toxic encephalomyelopathy in a 12-year-old girl due to prophylactic intrathecal injection of methotrexate and cytosine arabinoside, with a characteristic progressive symptomatology leading to death after 28 days. The location and type of neuropathological changes support

Selective use of daunorubicin for remiss

Selective use of daunorubicin for remission-induction chemotherapy in acute non-lymphoblastic leukemia

✍ B. S. Shaikh; J. B. Dougherty; R. W. Hamilton; J. O. Ballard; S. B. Patel; N. R. 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 396 KB 👁 2 views

Twenty-eight patients with acute non-lymphoblastic leukemia (ANLL) were started on induction chemotherapy consisting of Cytosine Arbinoside (Ara C) and 6 thioguanine (TG). Daunoruhicin (DNR) was used selectively in 20 of 28 patients who failed to respond by day 14 to the Ara C and TG combination. Se

Sequentisl induction chemotherapy with v

Sequentisl induction chemotherapy with vincristine, daunorubicin cyclophosphamide, and prednisone in adult acute lymphoblastic leukemia

✍ X. Thomas; C. Danaila; Q. K. Bach; C. Sebban; E. Archimbaud; D. Fiere; P. Dufour 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 495 KB